Speyer J - Search Results

1

4'Epidoxorubicin (epirubicin): activity in hepatocellular carcinoma.

Hochster HS, Green MD, Speyer J, Fazzini E, Blum R, Muggia FM. Hochster HS, et al. Among authors: speyer j. J Clin Oncol. 1985 Nov;3(11):1535-40. doi: 10.1200/JCO.1985.3.11.1535. J Clin Oncol. 1985. PMID: 2997408

2

Phase II trial of cyclophosphamide and cis-platinum for non-small cell bronchogenic carcinoma.

Schmidt AM, Blum RH, Clayton M, Speyer JL, Bottino J, Muggia FM. Schmidt AM, et al. Among authors: speyer jl. Am J Clin Oncol. 1984 Dec;7(6):725-7. doi: 10.1097/00000421-198412000-00023. Am J Clin Oncol. 1984. PMID: 6543291

3

Oxaliplatin with weekly bolus fluorouracil and low-dose leucovorin as first-line therapy for patients with colorectal cancer.

Hochster H, Chachoua A, Speyer J, Escalon J, Zeleniuch-Jacquotte A, Muggia F. Hochster H, et al. Among authors: speyer j. J Clin Oncol. 2003 Jul 15;21(14):2703-7. doi: 10.1200/JCO.2003.02.071. J Clin Oncol. 2003. PMID: 12860947 Clinical Trial.

4

Biweekly 72-hour 9-aminocamptothecin infusion as second-line therapy for ovarian carcinoma: phase II study of the New York Gynecologic Oncology Group and the Eastern Cooperative Oncology Group.

Hochster H, Plimack ER, Runowicz CD, Speyer J, Wallach RC, Sorich J, Mandeli J, Wadler S, Wright J, Muggia FM. Hochster H, et al. Among authors: speyer j. J Clin Oncol. 2004 Jan 1;22(1):120-6. doi: 10.1200/JCO.2004.03.016. J Clin Oncol. 2004. PMID: 14701774 Clinical Trial.

5

Phase I trial of low-dose continuous topotecan infusion in patients with cancer: an active and well-tolerated regimen.

Hochster H, Liebes L, Speyer J, Sorich J, Taubes B, Oratz R, Wernz J, Chachoua A, Raphael B, Vinci RZ, et al. Hochster H, et al. Among authors: speyer j. J Clin Oncol. 1994 Mar;12(3):553-9. doi: 10.1200/JCO.1994.12.3.553. J Clin Oncol. 1994. PMID: 8120553 Clinical Trial.

6

Phase II trial of paclitaxel and cisplatin in women with advanced breast cancer: an active regimen with limiting neurotoxicity.

Wasserheit C, Frazein A, Oratz R, Sorich J, Downey A, Hochster H, Chachoua A, Wernz J, Zeleniuch-Jacquotte A, Blum R, Speyer J. Wasserheit C, et al. Among authors: speyer j. J Clin Oncol. 1996 Jul;14(7):1993-9. doi: 10.1200/JCO.1996.14.7.1993. J Clin Oncol. 1996. PMID: 8683229 Clinical Trial.

7

Activity and pharmacodynamics of 21-Day topotecan infusion in patients with ovarian cancer previously treated with platinum-based chemotherapy. New York Gynecologic Oncology Group.

Hochster H, Wadler S, Runowicz C, Liebes L, Cohen H, Wallach R, Sorich J, Taubes B, Speyer J. Hochster H, et al. Among authors: speyer j. J Clin Oncol. 1999 Aug;17(8):2553-61. doi: 10.1200/JCO.1999.17.8.2553. J Clin Oncol. 1999. PMID: 10561322 Clinical Trial.

8

Intraperitoneal carboplatin: favorable results in women with minimal residual ovarian cancer after cisplatin therapy.

Speyer JL, Beller U, Colombo N, Sorich J, Wernz JC, Hochster H, Green M, Porges R, Muggia FM, Canetta R, et al. Speyer JL, et al. J Clin Oncol. 1990 Aug;8(8):1335-41. doi: 10.1200/JCO.1990.8.8.1335. J Clin Oncol. 1990. PMID: 2199620

9

Activity of epirubicin in pancreatic carcinoma.

Hochster H, Green MD, Speyer JL, Wernz JC, Blum RH, Muggia FM. Hochster H, et al. Among authors: speyer jl. Cancer Treat Rep. 1986 Feb;70(2):299-300. Cancer Treat Rep. 1986. PMID: 3456273 No abstract available.

10

Prospective evaluation of cardiotoxicity during a six-hour doxorubicin infusion regimen in women with adenocarcinoma of the breast.

Speyer JL, Green MD, Dubin N, Blum RH, Wernz JC, Roses D, Sanger J, Muggia FM. Speyer JL, et al. Am J Med. 1985 Apr;78(4):555-63. doi: 10.1016/0002-9343(85)90395-x. Am J Med. 1985. PMID: 3838618

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters